SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001445546-22-008345 from FT 10473 (CIK 0001945129)

FT 10473 (CIK 0001945129)
Date: Dec. 6, 2022 · CIK: 0001945129 · Accession: 0001445546-22-008345

Financial Reporting Risk Disclosure Regulatory Compliance

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-268374

Date
December 6, 2022
Author
Daniel J. Fallon
Form
CORRESP
Company
FT 10473 (CIK 0001945129)

Letter

Division of Investment Management Re: FT 10473 Balanced Income Equity and ETF Portfolio, Series 59 (the “Trust”) CIK No. 1945129 File No. 333-268374

Dear Mr. Cowan:

We received your comments regarding the Registration Statement for the above captioned Trust. This letter serves to respond to your comments.

Comments

General

1.Please confirm that the valuation disclosure in the Registration Statement has been updated per Rule 2a-5.

Response:The Trust confirms all valuation disclosure in the Registration Statement is accurate and in compliance with Rule 2a-5.

Portfolio

2.If a principal investment of the Trust, please also add distressed debt securities to the list of investment types that the ETF portion of the Trust invests in (consistent with the risk disclosure).

Response:The Trust notes that while distressed debt securities do not rise to a level of principal investment for the Trust, the Trust believes the current risk disclosure is adequate and necessary for investor comprehension as the distressed debt securities risk disclosure is substantially related to the high-yield securities risk disclosure. As such, the Trust respectfully declines to add distressed debt securities to the Portfolio Selection Process section.

Risk Factors

3.If the Funds held by the Trust invest in bonds that reference LIBOR, please add relevant risk disclosure.

Response:If, based on the Trust’s final portfolio, the Trust has exposure to Funds that invest in bonds that reference LIBOR, appropriate disclosure will be added to the prospectus.

4.If the Trust will have material exposure to China, please disclose the risks associated with investments in China.

Response: If the Trust has material exposure to China, based on its final portfolio, relevant risk disclosure will be added to the Trust’s prospectus.

5.Please include the risks of investing in small and/or mid-capitalization companies, as the “Additional Portfolio Contents” section states the Trust will invest in companies with various market capitalizations.

Response: If, based on its final portfolio, the Trust has exposure to small and/or mid-capitalization companies either directly or through the underlying Funds, relevant risk disclosure will be added to the Trust’s prospectus. Otherwise, the “Additional Portfolio Contents” section will be revised.

We appreciate your prompt attention to this Registration Statement. If you have any questions or comments or would like to discuss our responses to your questions, please feel free to contact Brian D. Free at (312) 845-3017 or the undersigned at (312) 845-3721.

Very truly yours,
Chapman and Cutler llp

Show Raw Text
CORRESP
1
filename1.htm

        Chapman and Cutler LLP

320 South Canal Street, 27th Floor

Chicago, Illinois 60606

T 312.845.3000

F 312.701.2361

www.chapman.com

December 6, 2022

Mark Cowan

U.S. Securities and Exchange Commission

Division of Investment Management

Disclosure Review Office

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    FT 10473

    Balanced Income Equity and ETF Portfolio, Series 59

    (the “Trust”)

    CIK No. 1945129 File No. 333-268374

Dear Mr. Cowan:

We received your comments
regarding the Registration Statement for the above captioned Trust. This letter serves to respond to your comments.

Comments

General

1.Please
confirm that the valuation disclosure in the Registration Statement has been updated per Rule 2a-5.

Response:The
Trust confirms all valuation disclosure in the Registration Statement is accurate and in compliance with Rule 2a-5.

Portfolio

2.If
a principal investment of the Trust, please also add distressed debt securities to the list of investment types that the ETF portion of
the Trust invests in (consistent with the risk disclosure).

Response:The Trust notes that
while distressed debt securities do not rise to a level of principal investment for the Trust, the Trust believes the current risk disclosure
is adequate and necessary for investor comprehension as the distressed debt securities risk disclosure is substantially related to the
high-yield securities risk disclosure. As such, the Trust respectfully declines to add distressed debt securities to the Portfolio Selection
Process section.

Risk Factors

3.If
the Funds held by the Trust invest in bonds that reference LIBOR, please add relevant risk disclosure.

Response:If, based on the
Trust’s final portfolio, the Trust has exposure to Funds that invest in bonds that reference LIBOR, appropriate disclosure will
be added to the prospectus.

4.If
the Trust will have material exposure to China, please disclose the risks associated with investments in China.

Response: If the Trust has
material exposure to China, based on its final portfolio, relevant risk disclosure will be added to the Trust’s prospectus.

5.Please
include the risks of investing in small and/or mid-capitalization companies, as the “Additional Portfolio Contents” section
states the Trust will invest in companies with various market capitalizations.

Response: If, based on its
final portfolio, the Trust has exposure to small and/or mid-capitalization companies either directly or through the underlying Funds,
relevant risk disclosure will be added to the Trust’s prospectus. Otherwise, the “Additional Portfolio Contents” section
will be revised.

We appreciate your prompt attention to this Registration
Statement. If you have any questions or comments or would like to discuss our responses to your questions, please feel free to contact
Brian D. Free at (312) 845-3017 or the undersigned at (312) 845-3721.

    Very truly yours,

    Chapman and Cutler llp

    By:
    /s/ Daniel J. Fallon

    Daniel J. Fallon